(Q40668592)

22 September 2017

title

Fludarabine in resistant or relapsing B-cell chronic lymphocytic leukemia: the Spanish Group experience (English)

1 reference

B-cell chronic lymphocytic leukemia

22 September 2017

0 references

1 reference

1 reference

Montserrat E

1

1 reference

22 September 2017

Lopez-Lorenzo JL

2

1 reference

22 September 2017

Manso F

3

1 reference

22 September 2017

Martin A

4

1 reference

22 September 2017

Prieto E

5

1 reference

22 September 2017

Arias-Sampedro J

6

1 reference

22 September 2017

Fernandez MN

7

1 reference

22 September 2017

Oyarzabal FJ

8

1 reference

22 September 2017

Odriozola J

9

1 reference

22 September 2017

Alcala A

10

1 reference

22 September 2017

Garcia-Conde J

11

1 reference

22 September 2017

Guardia R

12

1 reference

22 September 2017

Bosch F

13

1 reference

22 September 2017

publication date

1 May 1996

1 reference

22 September 2017

1 reference

22 September 2017

volume

21

1 reference

22 September 2017

issue

5-6

1 reference

22 September 2017

page(s)

467-472

1 reference

CHOP Versus Chlorambucil + Prednisolone in Chronic Lymphocytic Leukemia.

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F10428199609093445

Nucleoside analogs in treatment of chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199609093445

Guidelines for clinical protocols for chronic lymphocytic leukemia: recommendations of the National Cancer Institute-sponsored working group

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199609093445

A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199609093445

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199609093445

352. Note: Conservatism of the Approximation Σ(O - E) 2 /E in the Logrank Test for Survival Data or Tumor Incidence Data

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199609093445

Activity of fludarabine in refractory chronic lymphocytic leukemia and low grade non-Hodgkin's lymphoma--the Jerusalem experience

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199609093445

Listeriosis in patients with chronic lymphocytic leukemia who were treated with fludarabine and prednisone

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199609093445

Opportunistic pulmonary infections with fludarabine in previously treated patients with low-grade lymphoid malignancies: a role for Pneumocystis carinii pneumonia prophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199609093445

Autoimmunity in chronic lymphocytic leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199609093445

Treatment of advanced chronic lymphocytic leukemia by fludarabine

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199609093445

10.3109/10428199609093445

21 January 2018

Identifiers

DOI

1 reference

22 September 2017

1 reference